Surgeons to Observe and Discuss Live Eye Surgery Friday Night in Boston
Bausch & Lomb Premium Cataract Intraocular Lenses to Be Featured
FOR RELEASE WEDNESDAY, APRIL 7, 2010
BOSTON- Over 1,000 cataract surgeons will attend a live surgery
and symposium at a Boston hotel Friday night. They will observe two
surgical procedures conducted by Dr. Jeffrey Whitman broadcast live
from Key Whitman Eye Center in Dallas, Texas. Dr. Whitman will
implant the Crystalens AO, the only FDA approved
accommodating intraocular lens (IOL) in one patient and the
Akreos™ MICS lens in another patient. Surgeons will be able to
observe and discuss the surgery during the Friday evening event.
"I'm honored to be sharing this experience with the surgeons who
will be watching live in Boston. It promises to be an excellent
experience for all of us. This opportunity to observe and discuss a
surgery benefits both surgeons and our cataract and presbyopic
patients," said Dr. Jeffrey Whitman.
The live surgery and symposium - entitled "Celebrating
Innovations in Premium and Micro-Incision Advanced Optics Live
Surgery and Symposium” - will be held at the Boston Sheraton Hotel
in Boston on Friday night, April 9. It is being sponsored by Bausch
+ Lomb. The American Society of Cataract and Refractive Surgery’s
(ASCRS) Annual Meeting is being held at the Boston Convention &
Exhibition Center and has attracted thousands of surgeons to the
"Bausch + Lomb is pleased to sponsor this live surgery and
symposium event. There are many premium solutions available to
cataract surgeons today and this type of symposium provides an
excellent opportunity for surgeons to share new surgical techniques
and ideas with each other which benefit all of us in the industry,
particularly the patient," said Tom Frinzi, vice-president of sales
for Bausch + Lomb Surgical."
There are 3 million cataract surgeries every year. A cataract is
a clouding on the normally clear lens in your eye. When it forms,
the natural lens in the patient's eye is replaced by an intraocular
lens. Advertising research indicated that only a small fraction of
people realized that not all intraocular lenses are the same. The
research also indicated that a number of patients are willing to pay
a little extra money in order to get the best vision.
Crystalens® AO is the only FDA approved
accommodating intraocular lens. Unlike the standard cataract
replacement lenses, Crystalens AO not only
eliminates the patient's cataract but also gives the patient full
range of vision so that the patient can see near, far and everything
in between. Many Crystalens patients hardly ever need their
glasses or contacts again.
The Akreos MICS lens - also made by Bausch +
Lomb - is the final step on the path to sub 2 mm microincision
cataract surgery. The lens is inserted through a 1.8mm incision and
provides exceptional vision quality and contrast sensitivity with an
In both surgeries, the patient's natural lens will be removed by
the Stellaris™ Vision Enhancement System which creates a
removal incision of only 1.8 mm, which is the smallest incision
currently available to surgeons and their patients. The smaller
incision complements the surgical technique and helps develop
positive patient results.
For more information about the Crystalens HD and the
Akreos MICS lens and the Stellaris, please visit
About Bausch + Lomb
Bausch + Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch & Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.
Crystalens is a registered trademark of Bausch & Lomb.
Akreos is a registered trademark of Bausch & Lomb.
Stellaris is a registered trademark of Bausch & Lomb.